Erbitux slightly boosts survival in cancer study

June 1, 2008 By MARILYNN MARCHIONE, AP Medical Writer

(AP) -- Adding the novel cancer drug Erbitux to standard chemotherapy helped advanced lung cancer patients live just a month longer than chemo alone, a study found.

Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

Similar stories from PHYSorg:

Adding cetuximab to chemotherapy reduces advanced lung cancer death risk by 13 percent

Sep 22, 2009 | not rated yet | 0

Novel 4-drug combination proves safe for lung cancer treatment

Nov 13, 2008 | 5 / 5 (1) | 1

New York doctors testing heated chemo for rare cancer

Mar 05, 2009 | not rated yet | 1

Surgery remans an option for advanced lung cancer

Jul 27, 2009 | not rated yet | 1

Study shows drug combination improves outcome for advanced non-small cell lung cancer

May 31, 2009 | 5 / 5 (1) | 0

Rate this story - not rated yet

rank
1
2
3
4
5

view popular

Other News

Climate variability and dengue incidence

Medicine & Health / Diseases

37 minutes ago | not rated yet | 0

Research published this week in PLoS Medicine demonstrates associations between local rainfall and temperature and cases of dengue fever, which affects an estimated fifty million people per year worldwide. But the study ...

Early cooling in cardiac arrest may improve survival

Medicine & Health / Other

19 minutes ago | not rated yet | 0

Rapidly cooling a person in cardiac arrest may improve their chance of survival without brain damage, according to research presented at the American Heart Association's Scientific Sessions 2009.

Pilot study relates phthalate exposure to less-masculine play by boys

Medicine & Health / Research

2 hours ago | 4 / 5 (2) | 2

A study of 145 preschool children reports, for the first time, that when the concentrations of two common phthalates in mothers' prenatal urine are elevated their sons are less likely to play with male-typical toys and games, ...

New study links vitamin D deficiency to cardiovascular disease and death

Medicine & Health / Health

2 hours ago | not rated yet | 0

While mothers have known that feeding their kids milk builds strong bones, a new study by researchers at the Heart Institute at Intermountain Medical Center in Salt Lake City suggests that Vitamin D contributes to a strong ...

Study raises new questions about Merck pill Zetia

Medicine & Health / Medications

2 hours ago | not rated yet | 0

(AP) -- A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.